This study was based on a survey conducted using an antigen capture test to assess exposure to parvovirus in pet dogs. The vaccination status and prevalence of parvovirus were surveyed in 277 pet dogs from the Ga East and Ga West Districts of the Greater Accra region of Ghana. The study was carried out at the Veterinary Clinic of the Biotechnology and Nuclear Agriculture Research Institute (BNARI), Ghana Atomic Energy Commission. The samples included 150 males and 127 females, representing a diverse range of breeds. Most of the dogs were mixed breeds (n = 102), followed by local breeds (n = 62), hybrids (n = 53), and bull mastiffs (n = 6). Among the 277 dogs tested, 136 were positive for parvovirus, while 141 tested negative. The dogs had received various parvovirus vaccines, with the most commonly used being Biocan DHPPL (n = 55, 24.20%), followed by Zoetis (n = 31, 13.65%), and the Zoetis-Biocan combo (n = 28, 12.33%). There were notable gaps in vaccination coverage: 78 dogs had received only partial vaccinations, 83 had completed their vaccinations, and 116 had received no vaccinations at all. These results underscore the urgent need for targeted intervention measures to enhance vaccination uptake and prevent disease outbreaks in the canine community. The data offer valuable insights into the prevalence of parvovirus in dog populations and will inform policies aimed at improving the health and well-being of dogs.

Keywords: Parvovirus Disease Prevalence, Canine Vaccination; Immunization; Biocan DHPPL; Zoetis